Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Combination therapy for radiation sickness shows promise in mice

Dec. 30, 2011

BioDelivery Sciences reports on confirmatory BEMA-buprenorphine/naloxone trial

Dec. 22, 2011

Lundbeck reports on MAA for Selincro

Dec. 22, 2011

Paladin Labs launches product for digoxin toxicity and overdose in Canada

Dec. 15, 2011

NIDA to fund study of Biotie's nepicastat

Dec. 13, 2011

International team identifies potential therapeutic for cocaine addiction

Dec. 9, 2011

Titan Pharmaceuticals reports FDA regulatory guidance for Probuphine NDA

Dec. 5, 2011

Selecta Biosciences commences clinical trial of vaccine for smoking cessation

Nov. 23, 2011

BioDelivery Sciences begins dose-finding BNX-102 study

Nov. 11, 2011

BARDA awards contract to RxBio to develop radiomitigant countermeasure drug

Nov. 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...